MOSL: HEALTHCARE-Sales growth in low single-digits despite reasonable base
HEALTHCARE: Sales growth in low single-digits despite reasonable base
- Indian pharmaceutical market's (IPM) secondary sales hit single-digit growth of 5.1% YoY in Oct'19 (v/s 11.9% YoY in Sep'19 and 9.5% YoY in Aug'19), despite a reasonable base (12.5% YoY growth in Oct'18). Volumes declined 2.7% YoY in Oct'19 (lower than 12-month rolling average of 1.5% and v/s 3.5% in Sep'19). Price growth remained steady at 5.1% YoY while new launch growth was 2.5% YoY.
- For three months ended Oct'19, growth was 8.8% YoY. Overall growth was driven by 5.6% YoY increase in prices and 2.6% YoY rise in new launch growth. Volume growth at 0.7% (v/s 3.2% in 2QFY20) dragged overall growth. Notably, both national list of essential medicines (NLEM) products/Non-NLEM products reported growth of 10.4%/8.6% YoY for the quarter.
- On MAT basis, industry grew 9.2% YoY with price growth of 5.2% YoY, volume growth of 1.4% YoY and new launch growth of 2.6% YoY.
Motilal Oswal Financial Services Ltd. is a reputed name in Financial Services and Online Trading with group companies providing services such as Private Wealth Management, Retail Broking and Distribution, Institutional Broking, Asset Management, Investment Banking, Private Equity, Commodity Broking, Currency Broking, Principal Strategies & Home Finance.
Motilal Oswal Securities is a group company of Motilal Oswal Financial Service Limited which started as a stock trading company and has blossomed into well diversified firm offering a range of financial products and services. Motilal Oswal has built a reputation as the source for best stock trading company and this has taken a wealth of experience, knowledge and expertise, constantly working in tandem, over the years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.